Final OS analysis from the phase 3 TROPiCS-02 study: sacituzumab govitecan in HR+/HER2 - metastatic breast cancer Meeting Abstract
| Authors: | Rugo, H. S.; Bardia, A.; Marme, F.; Cortes, J.; Schmid, P.; Loirat, D.; Tredan, O.; Ciruelos, E.; Dalenc, F.; Pardo, P. G.; Jhaveri, K. L.; Delaney, R.; Valdez, T.; Yoon, O.; Wang, H.; Verret, W.; Tolaney, S. M. |
| Abstract Title: | Final OS analysis from the phase 3 TROPiCS-02 study: sacituzumab govitecan in HR+/HER2 - metastatic breast cancer |
| Meeting Title: | The Japanese Society of Medical Oncology Annual Meeting 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2024 Feb 22-24 |
| Meeting Location: | Nagoya, Japan |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-10-01 |
| Start Page: | S1314 |
| End Page: | S1315 |
| Language: | English |
| ACCESSION: | WOS:001345709300071 |
| DOI: | 10.1016/j.annonc.2024.07.716 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PS3-2 -- Source: Wos |
